Scientific publications

Scientific articles authored by Novo Nordisk

The information you can search here is retrieved via the database Current Contents®, covering 95% of publications within the life science area. Only articles authored by at least one researcher from Novo Nordisk are included in the search results. The database provides easy access to tables of contents, abstracts, bibliographic information, and abstracts from the most recently published issues of leading scholarly journals.

4628 results found.
Showing results 2821-2840
Journal Author Year
Diabetic Medicine

Similarity of pharmacodynamic effects of a single injection of insulin glargine, insulin detemir and NPH insulin on glucose metabolism assessed by 24-h euglycaemic clamp studies in healthy humans

Sorensen LP ; Brock B ; Mengel A ; Rungby J ; Moller N ; Nielsen S ; Volund A ; Schmitz O 2010
Diabetic Medicine

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril

Nielsen SE ; Schjoedt KJ ; Astrup AS ; Tarnow L ; Lajer M ; Hansen PR ; Parving HH ; Rossing P 2010
Diabetic Medicine

Performance of existing risk scores in screening for undiagnosed diabetes: an external validation study

Witte DR ; Shipley MJ ; Marmot MG ; Brunner EJ 2010
Diabetic Medicine

Advantages of insulin pump therapy

Akram K ; Pedersen-Bjergaard U ; Carstensen B ; Borch-Johnsen K ; Thorsteinsson B 2009
Diabetic Medicine

Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins

Arutchelvam V ; Heise T ; Dellweg S ; Elbroend B ; Minns I ; Home PD 2009
Diabetic Medicine

Symptoms of depression and diabetes-specific emotional distress are associated with a negative appraisal of insulin therapy in insulin-naive patients with Type 2 diabetes mellitus. A study from the European Depression in Diabetes [EDID] Research Consortium

Makine C ; Karsidag C ; Kadioglu P ; Ilkova H ; Karsidag K ; Skovlund SE ; Snoek FJ ; Pouwer F 2009
Diabetic Medicine

Socioeconomic factors related to attendance at a Type 2 diabetes screening programme

Dalsgaard EM ; Lauritzen T ; Christiansen T ; Mai KS ; Borch-Johnsen K ; Sandbaek A 2009
Diabetic Medicine

Predictors of future fasting and 2-h post-OGTT plasma glucose levels in middle-aged men and women-the Inter99 study

Faerch K ; Vaag A ; Witte DR ; Jorgensen T ; Pedersen O ; Borch-Johnsen K 2009
Diabetic Medicine

Safety and efficacy of inhaled insulin (AERx((R)) iDMS(1)) compared with subcutaneous insulin therapy in patients with Type 1 diabetes: 1-year data from a randomized, parallel group trial

Moses RG ; Bartley P ; Lunt H ; O'Brien RC ; Donnelly T ; Gall MA ; Vesterager A ; Wollmer P ; Roberts A 2009
Diabetic Medicine

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

Marre M ; Shaw J ; Brandle M ; Bebakar WMW ; Kamaruddin NA ; Strand J ; Zdravkovic M ; Le Thi TD ; Colagiuri S 2009
Diabetic Medicine

Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes

Hojberg PV ; Vilsboll T ; Zander M ; Knop FK ; Krarup T ; Volund A ; Holst JJ ; Madsbad S 2008
Diabetic Medicine

Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes

Courreges JP ; Vilsboll T ; Zdravkovic M ; Le-Thi T ; Krarup T ; Schmitz O ; Verhoeven R ; Buganova I ; Madsbad S 2008
Diabetic Medicine

Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus

Vilsboll T ; Brock B ; Perrild H ; Levin K ; Lervang HH ; Kolendorf K ; Krarup T ; Schmitz O ; Zdravkovic M ; Le-Thi T ; Madsbad S 2008
Diabetic Medicine

Does serum 1,5-anhydroglucitol establish a relationship between improvements in HbA(1c) and postprandial glucose excursions? Supportive evidence utilizing the differential effects between biphasic insulin aspart 30 and insulin glargine

Moses AC ; Raskin P ; Khutoryansky N 2008
Diabetic Medicine

Antibody response to insulin in children and adolescents with newly diagnosed Type 1 diabetes

Holmberg H ; Mersebach H ; Kanc K ; Ludvigsson J 2008
Diabetic Medicine

Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial

Bartley PC ; Bogoev M ; Larsen J ; Philotheou A 2008
Diabetic Medicine

Are family factors universally related to metabolic outcomes in adolescents with Type 1 diabetes?

Cameron FJ ; Skinner TC ; de Beaufort CE ; Hoey H ; Swift PGF ; Aanstoot H ; Aman J ; Martul P ; Chiarelli F ; Daneman D ; Danne T ; Dorchy H ; Kaprio EA ; Kaufman F ; Kocova M 2008
Diabetic Medicine

Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in Type 2 diabetes

Parkner T ; Laursen T ; Vestergaard ET ; Hartvig H ; Smedegaard JS ; Lauritzen T ; Christiansen JS 2008
Diabetic Medicine

Pregnancy-associated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy-a prospective follow-up study

Astrup AS ; Tarnow L ; Christiansen M ; Hansen PR ; Parving HH ; Rossing P 2007
Diabetic Medicine

An angled insertion technique using 6-mm needles markedly reduces the risk of intramuscular injections in children and adolescents

Hofman PL ; Lawton SA ; Peart JM ; Holt JA ; Jefferies CA ; Robinson E ; Cutfield WS 2007